EF Hutton analyst Chip Moore maintains Applied UV (NASDAQ:AUVI) with a Buy and raises the price target from $2 to $2.5.
Unveiling Valuenomics: The Future of Digital Value
By Mohamed Ezeldin, Head of Tokenomics at Animoca Brands
EF Hutton Maintains Buy on Applied UV, Raises Price Target to $2.5
EF Hutton analyst Chip Moore maintains Applied UV (NASDAQ:AUVI) with a Buy and raises the price target from $2 to $2.5.
Related Posts
Analyst Ratings for Axon Enterprise
Analysts have provided the following ratings for Axon Enterprise (NASDAQ:AXON) within the last quarter: Bullish Somewhat Bullish Indifferent…
DA Davidson Maintains Buy on Affirm Holdings, Lowers Price Target to $20
DA Davidson analyst Christopher Brendler maintains Affirm Holdings (NASDAQ:AFRM) with a Buy and lowers the price target from $24 to $20.
Enliven Therapeutics Announces Proof Of Concept Data From Phase 1 Clinical Trial Of ELVN-001 In Chronic Myeloid Leukemia
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs Achieved initial cumulative MMR rate of